These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 8886876)
1. Symposium: ovarian tumors of borderline malignancy. Silva EG; Kurman RJ; Russell P; Scully RE Int J Gynecol Pathol; 1996 Oct; 15(4):281-302. PubMed ID: 8886876 [No Abstract] [Full Text] [Related]
2. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion. McKenney JK; Balzer BL; Longacre TA Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1. Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777 [TBL] [Abstract][Full Text] [Related]
4. Lymphatic vascular invasion in ovarian serous tumors of low malignant potential with stromal microinvasion: a case control study. Sangoi AR; McKenney JK; Dadras SS; Longacre TA Am J Surg Pathol; 2008 Feb; 32(2):261-8. PubMed ID: 18223329 [TBL] [Abstract][Full Text] [Related]
15. Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer. Gotlieb WH; Chetrit A; Menczer J; Hirsh-Yechezkel G; Lubin F; Friedman E; Modan B; Ben-Baruch G; Gynecol Oncol; 2005 Jun; 97(3):780-3. PubMed ID: 15893369 [TBL] [Abstract][Full Text] [Related]
16. Case 2. Spontaneous regression of peritoneal implants in borderline ovarian tumor after salpingo-oophorectomy. Morice P; Thoury A; Sabourin JC; Camatte S; Atallah D; Armand JP; Madelenat P; Duvillard P; Castaigne D J Clin Oncol; 2003 Sep; 21(18):3536-8. PubMed ID: 12972532 [No Abstract] [Full Text] [Related]
17. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors. Chang SJ; Ryu HS; Chang KH; Yoo SC; Yoon JH Acta Obstet Gynecol Scand; 2008; 87(4):476-81. PubMed ID: 18382877 [TBL] [Abstract][Full Text] [Related]
18. Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary. Ronnett BM; Shmookler BM; Sugarbaker PH; Kurman RJ Anat Pathol; 1997; 2():197-226. PubMed ID: 9575376 [TBL] [Abstract][Full Text] [Related]
19. Novel screening technique for dissemination potential of ovarian cancer cells to peritoneum. Fujimoto J; Hori M; Ichigo S; Morishita S; Tamaya T Invasion Metastasis; 1996; 16(6):302-7. PubMed ID: 9371229 [TBL] [Abstract][Full Text] [Related]
20. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia. Shibata K; Kajiyama H; Mizokami Y; Ino K; Nomura S; Mizutani S; Terauchi M; Kikkawa F Gynecol Oncol; 2005 Jul; 98(1):11-8. PubMed ID: 15907336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]